Stay updated on Alvelestat in alpha1-antitrypsin COPD: Clinical Trial
Sign up to get notified when there's something new on the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page.

Latest updates to the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page
- Check2 days agoChange DetectedThe banner about government funding-related operating status was removed from the page; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe study details and core information appear unchanged between screenshots; any differences are limited to visual layout and formatting.SummaryDifference0.4%

- Check45 days agoChange DetectedThe page is updated to reflect a new version (v3.2.0) and to add a prominent notice about government funding lapse and current operating status of NIH Clinical Center; the previous version reference (v3.1.0) was removed.SummaryDifference5%

- Check52 days agoChange DetectedContent updated to v3.1.0 and several drug-safety topics were removed; the page now emphasizes a newer version while reducing emphasis on health-safety sections.SummaryDifference0.6%

- Check66 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.SummaryDifference0.3%

- Check73 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%

Stay in the know with updates to Alvelestat in alpha1-antitrypsin COPD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page.